Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2026-05-15 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
北京市时代九和律师事务所关于华邦生命健康股份有限公司2025年年度股东会的法律意见书
AGM Information Classification · 90% confidence The document is a formal legal opinion issued by a law firm on the convening, attendance procedures, and resolutions of the company’s 2025 annual shareholders’ meeting (AGM). It verifies the legality of the meeting notices, voting procedures, and voting results. This type of legal opinion is part of the materials provided for the AGM. It is not itself an annual report or a regulatory notice of publication, nor is it a transcript or earnings release. Therefore it best fits AGM Information (materials shared at the Annual General Meeting).
2026-05-15 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions and detailed voting results for each proposal at the company’s 2025 Annual General Meeting (AGM), including share counts and percentages of votes for, against, and abstentions. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” rather than AGM materials or the full annual report. Therefore, it should be classified as DVA.
2026-05-15 Chinese
关于全资子公司获得《药品注册证书》的公告
Regulatory Filings
2026-05-07 Chinese
2025年度独立董事述职报告-刘忠海
Regulatory Filings
2026-04-22 Chinese
信息披露暂缓、豁免管理制度（2026年4月）
Regulatory Filings
2026-04-22 Chinese
关于2025年度利润分配预案的公告
Regulatory Filings
2026-04-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.